nodes	percent_of_prediction	percent_of_DWPC	metapath
Paclitaxel—Docetaxel—breast cancer	0.174	1	CrCtD
Paclitaxel—ovarian cancer—breast cancer	0.128	1	CtDrD
Paclitaxel—Microtubule Inhibition—Eribulin—breast cancer	0.107	0.414	CiPCiCtD
Paclitaxel—Microtubule Inhibition—Ixabepilone—breast cancer	0.107	0.414	CiPCiCtD
Paclitaxel—Cabazitaxel—Docetaxel—breast cancer	0.0974	1	CrCrCtD
Paclitaxel—Microtubule Inhibition—Docetaxel—breast cancer	0.0444	0.172	CiPCiCtD
Paclitaxel—TUBB3—breast cancer	0.0274	0.278	CbGaD
Paclitaxel—BCL2—breast cancer	0.0176	0.179	CbGaD
Paclitaxel—ABCC1—breast cancer	0.016	0.163	CbGaD
Paclitaxel—CYP1B1—breast cancer	0.0122	0.124	CbGaD
Paclitaxel—CYP19A1—breast cancer	0.00897	0.0912	CbGaD
Paclitaxel—ABCG2—breast cancer	0.00843	0.0857	CbGaD
Paclitaxel—TUBB4A—Eribulin—breast cancer	0.00475	0.0285	CbGbCtD
Paclitaxel—TUBB6—Eribulin—breast cancer	0.00475	0.0285	CbGbCtD
Paclitaxel—TUBB2A—Eribulin—breast cancer	0.00475	0.0285	CbGbCtD
Paclitaxel—TUBB3—Eribulin—breast cancer	0.00475	0.0285	CbGbCtD
Paclitaxel—TUBB8—Eribulin—breast cancer	0.00475	0.0285	CbGbCtD
Paclitaxel—TUBB2B—Eribulin—breast cancer	0.00475	0.0285	CbGbCtD
Paclitaxel—TUBB2A—Ixabepilone—breast cancer	0.00456	0.0273	CbGbCtD
Paclitaxel—TUBB2B—Ixabepilone—breast cancer	0.00456	0.0273	CbGbCtD
Paclitaxel—TUBB6—Ixabepilone—breast cancer	0.00456	0.0273	CbGbCtD
Paclitaxel—TUBB3—Ixabepilone—breast cancer	0.00456	0.0273	CbGbCtD
Paclitaxel—TUBB4A—Ixabepilone—breast cancer	0.00456	0.0273	CbGbCtD
Paclitaxel—TUBB8—Ixabepilone—breast cancer	0.00456	0.0273	CbGbCtD
Paclitaxel—CYP3A4—breast cancer	0.00421	0.0428	CbGaD
Paclitaxel—TUBB4B—Eribulin—breast cancer	0.00398	0.0238	CbGbCtD
Paclitaxel—TUBB1—Eribulin—breast cancer	0.00398	0.0238	CbGbCtD
Paclitaxel—TUBB—Eribulin—breast cancer	0.00398	0.0238	CbGbCtD
Paclitaxel—TUBB1—Ixabepilone—breast cancer	0.00381	0.0228	CbGbCtD
Paclitaxel—TUBB4B—Ixabepilone—breast cancer	0.00381	0.0228	CbGbCtD
Paclitaxel—TUBB—Ixabepilone—breast cancer	0.00381	0.0228	CbGbCtD
Paclitaxel—MAP4—Docetaxel—breast cancer	0.00375	0.0224	CbGbCtD
Paclitaxel—ABCB1—breast cancer	0.00351	0.0357	CbGaD
Paclitaxel—MAP2—Docetaxel—breast cancer	0.00271	0.0162	CbGbCtD
Paclitaxel—MAPT—Docetaxel—breast cancer	0.00271	0.0162	CbGbCtD
Paclitaxel—CYP19A1—Exemestane—breast cancer	0.00244	0.0146	CbGbCtD
Paclitaxel—TUBB3—Vinorelbine—breast cancer	0.00243	0.0146	CbGbCtD
Paclitaxel—TUBB6—Vinorelbine—breast cancer	0.00243	0.0146	CbGbCtD
Paclitaxel—TUBB8—Vinorelbine—breast cancer	0.00243	0.0146	CbGbCtD
Paclitaxel—TUBB2B—Vinorelbine—breast cancer	0.00243	0.0146	CbGbCtD
Paclitaxel—TUBB2A—Vinorelbine—breast cancer	0.00243	0.0146	CbGbCtD
Paclitaxel—TUBB4A—Vinorelbine—breast cancer	0.00243	0.0146	CbGbCtD
Paclitaxel—BCL2—Docetaxel—breast cancer	0.00215	0.0129	CbGbCtD
Paclitaxel—CYP19A1—Letrozole—breast cancer	0.00208	0.0124	CbGbCtD
Paclitaxel—TUBB1—Vinorelbine—breast cancer	0.00203	0.0122	CbGbCtD
Paclitaxel—TUBB—Vinorelbine—breast cancer	0.00203	0.0122	CbGbCtD
Paclitaxel—TUBB4B—Vinorelbine—breast cancer	0.00203	0.0122	CbGbCtD
Paclitaxel—CYP19A1—Anastrozole—breast cancer	0.00185	0.0111	CbGbCtD
Paclitaxel—TUBB6—Vinblastine—breast cancer	0.0015	0.00898	CbGbCtD
Paclitaxel—TUBB8—Vinblastine—breast cancer	0.0015	0.00898	CbGbCtD
Paclitaxel—TUBB4A—Vinblastine—breast cancer	0.0015	0.00898	CbGbCtD
Paclitaxel—TUBB2B—Vinblastine—breast cancer	0.0015	0.00898	CbGbCtD
Paclitaxel—TUBB3—Vinblastine—breast cancer	0.0015	0.00898	CbGbCtD
Paclitaxel—TUBB2A—Vinblastine—breast cancer	0.0015	0.00898	CbGbCtD
Paclitaxel—TUBB—Vinblastine—breast cancer	0.00125	0.00751	CbGbCtD
Paclitaxel—TUBB1—Vinblastine—breast cancer	0.00125	0.00751	CbGbCtD
Paclitaxel—TUBB4B—Vinblastine—breast cancer	0.00125	0.00751	CbGbCtD
Paclitaxel—TUBB3—Docetaxel—breast cancer	0.00124	0.0074	CbGbCtD
Paclitaxel—TUBB8—Docetaxel—breast cancer	0.00124	0.0074	CbGbCtD
Paclitaxel—TUBB6—Docetaxel—breast cancer	0.00124	0.0074	CbGbCtD
Paclitaxel—TUBB2A—Docetaxel—breast cancer	0.00124	0.0074	CbGbCtD
Paclitaxel—TUBB2B—Docetaxel—breast cancer	0.00124	0.0074	CbGbCtD
Paclitaxel—TUBB4A—Docetaxel—breast cancer	0.00124	0.0074	CbGbCtD
Paclitaxel—ABCC1—Idarubicin—breast cancer	0.00123	0.00736	CbGbCtD
Paclitaxel—ABCC10—Gemcitabine—breast cancer	0.00121	0.00724	CbGbCtD
Paclitaxel—NR1I2—Docetaxel—breast cancer	0.00112	0.00674	CbGbCtD
Paclitaxel—TUBB1—Docetaxel—breast cancer	0.00103	0.00619	CbGbCtD
Paclitaxel—TUBB4B—Docetaxel—breast cancer	0.00103	0.00619	CbGbCtD
Paclitaxel—TUBB—Docetaxel—breast cancer	0.00103	0.00619	CbGbCtD
Paclitaxel—CYP19A1—Raloxifene—breast cancer	0.000936	0.00561	CbGbCtD
Paclitaxel—ABCC10—Docetaxel—breast cancer	0.00079	0.00473	CbGbCtD
Paclitaxel—ABCB11—Tamoxifen—breast cancer	0.000763	0.00457	CbGbCtD
Paclitaxel—CYP1B1—Tamoxifen—breast cancer	0.000763	0.00457	CbGbCtD
Paclitaxel—CYP1B1—Mitoxantrone—breast cancer	0.000744	0.00446	CbGbCtD
Paclitaxel—CYP19A1—corpus luteum—breast cancer	0.000671	0.0557	CbGeAlD
Paclitaxel—CYP19A1—Tamoxifen—breast cancer	0.000618	0.0037	CbGbCtD
Paclitaxel—ABCC10—Doxorubicin—breast cancer	0.000589	0.00353	CbGbCtD
Paclitaxel—ABCC10—Methotrexate—breast cancer	0.00057	0.00342	CbGbCtD
Paclitaxel—ABCC1—Mitoxantrone—breast cancer	0.000528	0.00317	CbGbCtD
Paclitaxel—ABCB11—Vinblastine—breast cancer	0.000521	0.00312	CbGbCtD
Paclitaxel—SLCO1B3—Docetaxel—breast cancer	0.000441	0.00264	CbGbCtD
Paclitaxel—CYP1B1—Docetaxel—breast cancer	0.000429	0.00257	CbGbCtD
Paclitaxel—ABCC1—Epirubicin—breast cancer	0.000428	0.00256	CbGbCtD
Paclitaxel—ABCC1—Irinotecan—breast cancer	0.000416	0.00249	CbGbCtD
Paclitaxel—CYP2C9—Anastrozole—breast cancer	0.000403	0.00242	CbGbCtD
Paclitaxel—CYP3A5—Lapatinib—breast cancer	0.000401	0.0024	CbGbCtD
Paclitaxel—ABCC2—Tamoxifen—breast cancer	0.000401	0.0024	CbGbCtD
Paclitaxel—CYP2C8—Lapatinib—breast cancer	0.000386	0.00231	CbGbCtD
Paclitaxel—ABCC1—Vinblastine—breast cancer	0.00037	0.00222	CbGbCtD
Paclitaxel—ABCG2—Tamoxifen—breast cancer	0.000363	0.00217	CbGbCtD
Paclitaxel—ABCB1—Toremifene—breast cancer	0.000358	0.00214	CbGbCtD
Paclitaxel—ABCG2—Mitoxantrone—breast cancer	0.000354	0.00212	CbGbCtD
Paclitaxel—CYP1B1—Doxorubicin—breast cancer	0.00032	0.00192	CbGbCtD
Paclitaxel—ABCB11—Doxorubicin—breast cancer	0.00032	0.00192	CbGbCtD
Paclitaxel—SLCO1B3—Methotrexate—breast cancer	0.000318	0.00191	CbGbCtD
Paclitaxel—CYP3A4—Exemestane—breast cancer	0.000309	0.00185	CbGbCtD
Paclitaxel—ABCC2—Irinotecan—breast cancer	0.000308	0.00184	CbGbCtD
Paclitaxel—CYP2C9—Idarubicin—breast cancer	0.000306	0.00183	CbGbCtD
Paclitaxel—ABCC1—Docetaxel—breast cancer	0.000305	0.00183	CbGbCtD
Paclitaxel—ABCC2—Carboplatin—breast cancer	0.000294	0.00176	CbGbCtD
Paclitaxel—CYP2C8—Raloxifene—breast cancer	0.000292	0.00175	CbGbCtD
Paclitaxel—ABCG2—Irinotecan—breast cancer	0.000278	0.00167	CbGbCtD
Paclitaxel—ABCC2—Vinblastine—breast cancer	0.000274	0.00164	CbGbCtD
Paclitaxel—CYP3A7—Tamoxifen—breast cancer	0.000268	0.0016	CbGbCtD
Paclitaxel—CYP3A7-CYP3A51P—Tamoxifen—breast cancer	0.000268	0.0016	CbGbCtD
Paclitaxel—ABCG2—Fluorouracil—breast cancer	0.000267	0.0016	CbGbCtD
Paclitaxel—ABCG2—Carboplatin—breast cancer	0.000266	0.00159	CbGbCtD
Paclitaxel—CYP3A4—Letrozole—breast cancer	0.000263	0.00158	CbGbCtD
Paclitaxel—ABCB1—Lapatinib—breast cancer	0.000261	0.00156	CbGbCtD
Paclitaxel—MAP4—mammary gland—breast cancer	0.000259	0.0214	CbGeAlD
Paclitaxel—CYP3A4—Anastrozole—breast cancer	0.000234	0.0014	CbGbCtD
Paclitaxel—ABCC1—Doxorubicin—breast cancer	0.000227	0.00136	CbGbCtD
Paclitaxel—ABCC2—Docetaxel—breast cancer	0.000226	0.00135	CbGbCtD
Paclitaxel—ABCC1—Methotrexate—breast cancer	0.00022	0.00132	CbGbCtD
Paclitaxel—CYP3A4—Toremifene—breast cancer	0.000214	0.00128	CbGbCtD
Paclitaxel—CYP3A7—Irinotecan—breast cancer	0.000206	0.00123	CbGbCtD
Paclitaxel—CYP3A7-CYP3A51P—Irinotecan—breast cancer	0.000206	0.00123	CbGbCtD
Paclitaxel—ABCG2—Docetaxel—breast cancer	0.000204	0.00122	CbGbCtD
Paclitaxel—CYP3A5—Tamoxifen—breast cancer	0.000201	0.0012	CbGbCtD
Paclitaxel—CYP3A4—Fulvestrant—breast cancer	0.000199	0.00119	CbGbCtD
Paclitaxel—CYP2C8—Tamoxifen—breast cancer	0.000193	0.00116	CbGbCtD
Paclitaxel—CYP3A4—Thiotepa—breast cancer	0.000178	0.00106	CbGbCtD
Paclitaxel—MAP4—embryo—breast cancer	0.000177	0.0146	CbGeAlD
Paclitaxel—Cabazitaxel—TUBB3—breast cancer	0.000175	0.19	CrCbGaD
Paclitaxel—MAP2—nipple—breast cancer	0.000168	0.014	CbGeAlD
Paclitaxel—ABCC2—Doxorubicin—breast cancer	0.000168	0.00101	CbGbCtD
Paclitaxel—CYP2C9—Capecitabine—breast cancer	0.000167	0.001	CbGbCtD
Paclitaxel—ABCC2—Methotrexate—breast cancer	0.000163	0.000976	CbGbCtD
Paclitaxel—CYP3A4—Ixabepilone—breast cancer	0.000163	0.000974	CbGbCtD
Paclitaxel—CYP3A4—Lapatinib—breast cancer	0.000156	0.000937	CbGbCtD
Paclitaxel—CYP3A5—Irinotecan—breast cancer	0.000154	0.000924	CbGbCtD
Paclitaxel—ABCG2—Doxorubicin—breast cancer	0.000152	0.000911	CbGbCtD
Paclitaxel—CYP3A7-CYP3A51P—Docetaxel—breast cancer	0.000151	0.000903	CbGbCtD
Paclitaxel—CYP3A7—Docetaxel—breast cancer	0.000151	0.000903	CbGbCtD
Paclitaxel—MAPT—pituitary gland—breast cancer	0.000149	0.0123	CbGeAlD
Paclitaxel—MAPT—adipose tissue—breast cancer	0.000148	0.0123	CbGeAlD
Paclitaxel—ABCG2—Methotrexate—breast cancer	0.000147	0.000883	CbGbCtD
Paclitaxel—ABCB1—Vinorelbine—breast cancer	0.000145	0.000868	CbGbCtD
Paclitaxel—CYP2C8—Fluorouracil—breast cancer	0.000142	0.000853	CbGbCtD
Paclitaxel—TUBB6—mammary gland—breast cancer	0.000141	0.0117	CbGeAlD
Paclitaxel—Docetaxel—TUBB3—breast cancer	0.000141	0.153	CrCbGaD
Paclitaxel—MAP2—embryo—breast cancer	0.000139	0.0115	CbGeAlD
Paclitaxel—NR1I2—endocrine gland—breast cancer	0.000138	0.0115	CbGeAlD
Paclitaxel—MAP4—skin of body—breast cancer	0.000137	0.0114	CbGeAlD
Paclitaxel—CYP2C9—Tamoxifen—breast cancer	0.000135	0.000807	CbGbCtD
Paclitaxel—MAPT—adrenal gland—breast cancer	0.000133	0.011	CbGeAlD
Paclitaxel—BCL2—epithelium—breast cancer	0.000131	0.0109	CbGeAlD
Paclitaxel—ABCB1—Tamoxifen—breast cancer	0.000131	0.000783	CbGbCtD
Paclitaxel—ABCB1—Mitoxantrone—breast cancer	0.000128	0.000764	CbGbCtD
Paclitaxel—TUBB2B—nipple—breast cancer	0.000126	0.0104	CbGeAlD
Paclitaxel—BCL2—skin of body—breast cancer	0.000125	0.0103	CbGeAlD
Paclitaxel—Cabazitaxel—SLCO1B1—breast cancer	0.000124	0.134	CrCbGaD
Paclitaxel—TUBB4B—mammary gland—breast cancer	0.000123	0.0102	CbGeAlD
Paclitaxel—TUBB—nipple—breast cancer	0.000119	0.00987	CbGeAlD
Paclitaxel—MAP4—uterus—breast cancer	0.000119	0.00987	CbGeAlD
Paclitaxel—CYP3A4—Raloxifene—breast cancer	0.000119	0.00071	CbGbCtD
Paclitaxel—TUBB2A—nipple—breast cancer	0.000118	0.00982	CbGeAlD
Paclitaxel—BCL2—endometrium—breast cancer	0.000117	0.00974	CbGeAlD
Paclitaxel—TUBB6—nipple—breast cancer	0.000117	0.00969	CbGeAlD
Paclitaxel—MAP4—adipose tissue—breast cancer	0.000116	0.00965	CbGeAlD
Paclitaxel—TUBB1—adipose tissue—breast cancer	0.000114	0.00944	CbGeAlD
Paclitaxel—CYP3A5—Docetaxel—breast cancer	0.000113	0.000677	CbGbCtD
Paclitaxel—ABCB1—Gemcitabine—breast cancer	0.000113	0.000675	CbGbCtD
Paclitaxel—BCL2—uterus—breast cancer	0.000108	0.00897	CbGeAlD
Paclitaxel—TUBB4A—embryo—breast cancer	0.000107	0.00891	CbGeAlD
Paclitaxel—MAP4—female reproductive system—breast cancer	0.000107	0.00887	CbGeAlD
Paclitaxel—MAP4—adrenal gland—breast cancer	0.000104	0.00866	CbGeAlD
Paclitaxel—SLCO1B3—pituitary gland—breast cancer	0.000102	0.00849	CbGeAlD
Paclitaxel—ABCC10—nipple—breast cancer	0.000102	0.00848	CbGeAlD
Paclitaxel—MAP2—endometrium—breast cancer	0.000102	0.00843	CbGeAlD
Paclitaxel—TUBB4B—nipple—breast cancer	0.000102	0.00842	CbGeAlD
Paclitaxel—ABCB1—Irinotecan—breast cancer	0.0001	0.000601	CbGbCtD
Paclitaxel—CYP2C9—Fluorouracil—breast cancer	9.93e-05	0.000595	CbGbCtD
Paclitaxel—TUBB1—bone marrow—breast cancer	9.88e-05	0.00819	CbGeAlD
Paclitaxel—MAP4—female gonad—breast cancer	9.74e-05	0.00807	CbGeAlD
Paclitaxel—BCL2—female reproductive system—breast cancer	9.73e-05	0.00807	CbGeAlD
Paclitaxel—CYP1B1—mammary gland—breast cancer	9.73e-05	0.00806	CbGeAlD
Paclitaxel—MAP2—pituitary gland—breast cancer	9.21e-05	0.00763	CbGeAlD
Paclitaxel—BCL2—bone marrow—breast cancer	9.18e-05	0.00761	CbGeAlD
Paclitaxel—MAP2—adipose tissue—breast cancer	9.17e-05	0.0076	CbGeAlD
Paclitaxel—Docetaxel—BCL2—breast cancer	9.1e-05	0.0987	CrCbGaD
Paclitaxel—MAP4—endocrine gland—breast cancer	9.06e-05	0.00751	CbGeAlD
Paclitaxel—ABCB1—Vinblastine—breast cancer	8.93e-05	0.000535	CbGbCtD
Paclitaxel—BCL2—female gonad—breast cancer	8.85e-05	0.00734	CbGeAlD
Paclitaxel—BCL2—Tamoxifen—Toremifene—breast cancer	8.82e-05	0.231	CbGdCrCtD
Paclitaxel—TUBB6—Zalcitabine—Gemcitabine—breast cancer	8.77e-05	0.229	CbGdCrCtD
Paclitaxel—CYP3A4—Vinorelbine—breast cancer	8.68e-05	0.00052	CbGbCtD
Paclitaxel—MAP2—female reproductive system—breast cancer	8.43e-05	0.00699	CbGeAlD
Paclitaxel—TUBB4B—embryo—breast cancer	8.38e-05	0.00695	CbGeAlD
Paclitaxel—TUBB4A—skin of body—breast cancer	8.34e-05	0.00691	CbGeAlD
Paclitaxel—Docetaxel—ABCC1—breast cancer	8.25e-05	0.0894	CrCbGaD
Paclitaxel—BCL2—endocrine gland—breast cancer	8.23e-05	0.00683	CbGeAlD
Paclitaxel—MAP2—adrenal gland—breast cancer	8.22e-05	0.00682	CbGeAlD
Paclitaxel—MAPT—lymph node—breast cancer	7.96e-05	0.0066	CbGeAlD
Paclitaxel—SLCO1B3—endocrine gland—breast cancer	7.93e-05	0.00657	CbGeAlD
Paclitaxel—TUBB6—epithelium—breast cancer	7.87e-05	0.00652	CbGeAlD
Paclitaxel—CYP3A4—Tamoxifen—breast cancer	7.83e-05	0.000469	CbGbCtD
Paclitaxel—MAP2—female gonad—breast cancer	7.67e-05	0.00636	CbGeAlD
Paclitaxel—CYP3A4—Mitoxantrone—breast cancer	7.64e-05	0.000458	CbGbCtD
Paclitaxel—TUBB2B—endometrium—breast cancer	7.6e-05	0.0063	CbGeAlD
Paclitaxel—TUBB2A—skin of body—breast cancer	7.59e-05	0.00629	CbGeAlD
Paclitaxel—TUBB6—skin of body—breast cancer	7.48e-05	0.0062	CbGeAlD
Paclitaxel—CYP2C8—mammary gland—breast cancer	7.45e-05	0.00617	CbGeAlD
Paclitaxel—ABCB1—Docetaxel—breast cancer	7.36e-05	0.000441	CbGbCtD
Paclitaxel—TUBB4A—uterus—breast cancer	7.24e-05	0.00601	CbGeAlD
Paclitaxel—ABCC1—nipple—breast cancer	7.24e-05	0.006	CbGeAlD
Paclitaxel—TUBB—endometrium—breast cancer	7.19e-05	0.00596	CbGeAlD
Paclitaxel—TUBB2A—endometrium—breast cancer	7.15e-05	0.00593	CbGeAlD
Paclitaxel—MAP2—endocrine gland—breast cancer	7.13e-05	0.00591	CbGeAlD
Paclitaxel—TUBB6—endometrium—breast cancer	7.05e-05	0.00585	CbGeAlD
Paclitaxel—TUBB2B—pituitary gland—breast cancer	6.88e-05	0.0057	CbGeAlD
Paclitaxel—TUBB2B—adipose tissue—breast cancer	6.85e-05	0.00568	CbGeAlD
Paclitaxel—ABCB11—endocrine gland—breast cancer	6.84e-05	0.00567	CbGeAlD
Paclitaxel—CYP3A7—endocrine gland—breast cancer	6.69e-05	0.00554	CbGeAlD
Paclitaxel—TUBB—uterus—breast cancer	6.63e-05	0.00549	CbGeAlD
Paclitaxel—CYP2C9—mammary gland—breast cancer	6.62e-05	0.00548	CbGeAlD
Paclitaxel—TUBB2A—uterus—breast cancer	6.59e-05	0.00546	CbGeAlD
Paclitaxel—TUBB4A—female reproductive system—breast cancer	6.51e-05	0.0054	CbGeAlD
Paclitaxel—TUBB—pituitary gland—breast cancer	6.51e-05	0.00539	CbGeAlD
Paclitaxel—TUBB4B—skin of body—breast cancer	6.5e-05	0.00539	CbGeAlD
Paclitaxel—TUBB6—uterus—breast cancer	6.5e-05	0.00539	CbGeAlD
Paclitaxel—TUBB—adipose tissue—breast cancer	6.48e-05	0.00537	CbGeAlD
Paclitaxel—TUBB2A—pituitary gland—breast cancer	6.47e-05	0.00537	CbGeAlD
Paclitaxel—TUBB2A—adipose tissue—breast cancer	6.45e-05	0.00534	CbGeAlD
Paclitaxel—TUBB6—pituitary gland—breast cancer	6.38e-05	0.00529	CbGeAlD
Paclitaxel—TUBB6—adipose tissue—breast cancer	6.36e-05	0.00527	CbGeAlD
Paclitaxel—TUBB4A—adrenal gland—breast cancer	6.36e-05	0.00527	CbGeAlD
Paclitaxel—Docetaxel—CYP1B1—breast cancer	6.31e-05	0.0684	CrCbGaD
Paclitaxel—TUBB2B—female reproductive system—breast cancer	6.29e-05	0.00522	CbGeAlD
Paclitaxel—MAP4—lymph node—breast cancer	6.26e-05	0.00519	CbGeAlD
Paclitaxel—ABCC10—endometrium—breast cancer	6.18e-05	0.00512	CbGeAlD
Paclitaxel—TUBB2B—adrenal gland—breast cancer	6.14e-05	0.00509	CbGeAlD
Paclitaxel—TUBB4B—endometrium—breast cancer	6.13e-05	0.00508	CbGeAlD
Paclitaxel—CYP3A4—Irinotecan—breast cancer	6.02e-05	0.00036	CbGbCtD
Paclitaxel—Docetaxel—EGFR—breast cancer	5.95e-05	0.0645	CrCbGaD
Paclitaxel—TUBB4A—female gonad—breast cancer	5.93e-05	0.00491	CbGeAlD
Paclitaxel—TUBB2A—female reproductive system—breast cancer	5.93e-05	0.00491	CbGeAlD
Paclitaxel—TUBB6—female reproductive system—breast cancer	5.84e-05	0.00484	CbGeAlD
Paclitaxel—TUBB—adrenal gland—breast cancer	5.81e-05	0.00482	CbGeAlD
Paclitaxel—TUBB2A—adrenal gland—breast cancer	5.78e-05	0.00479	CbGeAlD
Paclitaxel—TUBB2B—female gonad—breast cancer	5.73e-05	0.00475	CbGeAlD
Paclitaxel—TUBB6—adrenal gland—breast cancer	5.7e-05	0.00473	CbGeAlD
Paclitaxel—ABCC10—uterus—breast cancer	5.69e-05	0.00472	CbGeAlD
Paclitaxel—BCL2—lymph node—breast cancer	5.69e-05	0.00472	CbGeAlD
Paclitaxel—TUBB4B—uterus—breast cancer	5.65e-05	0.00468	CbGeAlD
Paclitaxel—TUBB—bone marrow—breast cancer	5.62e-05	0.00466	CbGeAlD
Paclitaxel—TUBB2A—bone marrow—breast cancer	5.59e-05	0.00464	CbGeAlD
Paclitaxel—ABCC10—pituitary gland—breast cancer	5.59e-05	0.00463	CbGeAlD
Paclitaxel—ABCC10—adipose tissue—breast cancer	5.57e-05	0.00461	CbGeAlD
Paclitaxel—TUBB4B—pituitary gland—breast cancer	5.55e-05	0.0046	CbGeAlD
Paclitaxel—TUBB4B—adipose tissue—breast cancer	5.53e-05	0.00458	CbGeAlD
Paclitaxel—TUBB6—bone marrow—breast cancer	5.52e-05	0.00457	CbGeAlD
Paclitaxel—TUBB4A—endocrine gland—breast cancer	5.51e-05	0.00457	CbGeAlD
Paclitaxel—ABCB1—Doxorubicin—breast cancer	5.48e-05	0.000329	CbGbCtD
Paclitaxel—TUBB—female gonad—breast cancer	5.42e-05	0.00449	CbGeAlD
Paclitaxel—TUBB2A—female gonad—breast cancer	5.39e-05	0.00447	CbGeAlD
Paclitaxel—Cabazitaxel—ABCG2—breast cancer	5.39e-05	0.0584	CrCbGaD
Paclitaxel—CYP3A4—Vinblastine—breast cancer	5.35e-05	0.00032	CbGbCtD
Paclitaxel—TUBB2B—endocrine gland—breast cancer	5.33e-05	0.00442	CbGeAlD
Paclitaxel—TUBB6—female gonad—breast cancer	5.32e-05	0.00441	CbGeAlD
Paclitaxel—ABCB1—Methotrexate—breast cancer	5.31e-05	0.000318	CbGbCtD
Paclitaxel—CYP19A1—endometrium—breast cancer	5.2e-05	0.00431	CbGeAlD
Paclitaxel—CYP1B1—skin of body—breast cancer	5.15e-05	0.00427	CbGeAlD
Paclitaxel—ABCC10—female reproductive system—breast cancer	5.12e-05	0.00424	CbGeAlD
Paclitaxel—TUBB4B—female reproductive system—breast cancer	5.08e-05	0.00421	CbGeAlD
Paclitaxel—TUBB2A—endocrine gland—breast cancer	5.01e-05	0.00416	CbGeAlD
Paclitaxel—ABCC10—adrenal gland—breast cancer	4.99e-05	0.00414	CbGeAlD
Paclitaxel—TUBB6—Clomifene—Toremifene—breast cancer	4.98e-05	0.13	CbGdCrCtD
Paclitaxel—TUBB4B—adrenal gland—breast cancer	4.96e-05	0.00411	CbGeAlD
Paclitaxel—TUBB6—endocrine gland—breast cancer	4.95e-05	0.0041	CbGeAlD
Paclitaxel—MAP2—lymph node—breast cancer	4.93e-05	0.00409	CbGeAlD
Paclitaxel—ABCC10—bone marrow—breast cancer	4.83e-05	0.004	CbGeAlD
Paclitaxel—TUBB4B—bone marrow—breast cancer	4.8e-05	0.00398	CbGeAlD
Paclitaxel—CYP19A1—uterus—breast cancer	4.79e-05	0.00397	CbGeAlD
Paclitaxel—CYP19A1—adipose tissue—breast cancer	4.68e-05	0.00388	CbGeAlD
Paclitaxel—ABCC10—female gonad—breast cancer	4.66e-05	0.00386	CbGeAlD
Paclitaxel—TUBB4B—female gonad—breast cancer	4.62e-05	0.00383	CbGeAlD
Paclitaxel—CYP1B1—uterus—breast cancer	4.48e-05	0.00371	CbGeAlD
Paclitaxel—TUBB—Azacitidine—Gemcitabine—breast cancer	4.47e-05	0.117	CbGdCrCtD
Paclitaxel—CYP3A4—Docetaxel—breast cancer	4.41e-05	0.000264	CbGbCtD
Paclitaxel—CYP1B1—pituitary gland—breast cancer	4.4e-05	0.00364	CbGeAlD
Paclitaxel—CYP1B1—adipose tissue—breast cancer	4.38e-05	0.00363	CbGeAlD
Paclitaxel—ABCC1—endometrium—breast cancer	4.37e-05	0.00362	CbGeAlD
Paclitaxel—Docetaxel—ABCG2—breast cancer	4.35e-05	0.0471	CrCbGaD
Paclitaxel—ABCC10—endocrine gland—breast cancer	4.33e-05	0.00359	CbGeAlD
Paclitaxel—CYP19A1—female reproductive system—breast cancer	4.3e-05	0.00357	CbGeAlD
Paclitaxel—TUBB4B—endocrine gland—breast cancer	4.3e-05	0.00356	CbGeAlD
Paclitaxel—CYP19A1—adrenal gland—breast cancer	4.2e-05	0.00348	CbGeAlD
Paclitaxel—ABCC2—female reproductive system—breast cancer	4.11e-05	0.00341	CbGeAlD
Paclitaxel—ABCC1—uterus—breast cancer	4.03e-05	0.00334	CbGeAlD
Paclitaxel—CYP1B1—female reproductive system—breast cancer	4.02e-05	0.00334	CbGeAlD
Paclitaxel—ABCC2—adrenal gland—breast cancer	4.01e-05	0.00332	CbGeAlD
Paclitaxel—ABCC1—pituitary gland—breast cancer	3.95e-05	0.00328	CbGeAlD
Paclitaxel—ABCC1—adipose tissue—breast cancer	3.94e-05	0.00326	CbGeAlD
Paclitaxel—CYP1B1—adrenal gland—breast cancer	3.93e-05	0.00326	CbGeAlD
Paclitaxel—CYP19A1—female gonad—breast cancer	3.92e-05	0.00325	CbGeAlD
Paclitaxel—TUBB4A—lymph node—breast cancer	3.81e-05	0.00316	CbGeAlD
Paclitaxel—CYP2C8—endometrium—breast cancer	3.72e-05	0.00308	CbGeAlD
Paclitaxel—TUBB2B—lymph node—breast cancer	3.68e-05	0.00305	CbGeAlD
Paclitaxel—CYP1B1—female gonad—breast cancer	3.66e-05	0.00304	CbGeAlD
Paclitaxel—CYP19A1—endocrine gland—breast cancer	3.64e-05	0.00302	CbGeAlD
Paclitaxel—ABCG2—endometrium—breast cancer	3.62e-05	0.003	CbGeAlD
Paclitaxel—ABCC1—adrenal gland—breast cancer	3.53e-05	0.00293	CbGeAlD
Paclitaxel—TUBB—lymph node—breast cancer	3.48e-05	0.00289	CbGeAlD
Paclitaxel—ABCC2—endocrine gland—breast cancer	3.48e-05	0.00288	CbGeAlD
Paclitaxel—TUBB2A—lymph node—breast cancer	3.47e-05	0.00287	CbGeAlD
Paclitaxel—TUBB6—lymph node—breast cancer	3.42e-05	0.00283	CbGeAlD
Paclitaxel—CYP1B1—endocrine gland—breast cancer	3.4e-05	0.00282	CbGeAlD
Paclitaxel—CYP2C8—pituitary gland—breast cancer	3.37e-05	0.00279	CbGeAlD
Paclitaxel—ABCG2—uterus—breast cancer	3.33e-05	0.00276	CbGeAlD
Paclitaxel—ABCC1—female gonad—breast cancer	3.29e-05	0.00273	CbGeAlD
Paclitaxel—CYP3A4—Doxorubicin—breast cancer	3.29e-05	0.000197	CbGbCtD
Paclitaxel—ABCG2—pituitary gland—breast cancer	3.27e-05	0.00271	CbGeAlD
Paclitaxel—ABCG2—adipose tissue—breast cancer	3.26e-05	0.0027	CbGeAlD
Paclitaxel—TUBB6—Tamoxifen—Toremifene—breast cancer	3.19e-05	0.0835	CbGdCrCtD
Paclitaxel—TUBB6—Clomifene—Tamoxifen—breast cancer	3.13e-05	0.0817	CbGdCrCtD
Paclitaxel—CYP2C8—female reproductive system—breast cancer	3.08e-05	0.00255	CbGeAlD
Paclitaxel—TUBB6—Toremifene—Tamoxifen—breast cancer	3.05e-05	0.0798	CbGdCrCtD
Paclitaxel—CYP3A5—adipose tissue—breast cancer	3.03e-05	0.00251	CbGeAlD
Paclitaxel—ABCC10—lymph node—breast cancer	2.99e-05	0.00248	CbGeAlD
Paclitaxel—TUBB4B—lymph node—breast cancer	2.97e-05	0.00246	CbGeAlD
Paclitaxel—ABCG2—adrenal gland—breast cancer	2.92e-05	0.00242	CbGeAlD
Paclitaxel—ABCG2—bone marrow—breast cancer	2.83e-05	0.00234	CbGeAlD
Paclitaxel—CYP2C9—female reproductive system—breast cancer	2.74e-05	0.00227	CbGeAlD
Paclitaxel—ABCG2—female gonad—breast cancer	2.73e-05	0.00226	CbGeAlD
Paclitaxel—Cabazitaxel—CYP3A4—breast cancer	2.69e-05	0.0292	CrCbGaD
Paclitaxel—CYP2C8—endocrine gland—breast cancer	2.61e-05	0.00216	CbGeAlD
Paclitaxel—CYP3A5—female gonad—breast cancer	2.53e-05	0.0021	CbGeAlD
Paclitaxel—CYP19A1—lymph node—breast cancer	2.52e-05	0.00209	CbGeAlD
Paclitaxel—ABCB1—embryo—breast cancer	2.44e-05	0.00202	CbGeAlD
Paclitaxel—ABCC2—lymph node—breast cancer	2.4e-05	0.00199	CbGeAlD
Paclitaxel—CYP1B1—lymph node—breast cancer	2.35e-05	0.00195	CbGeAlD
Paclitaxel—CYP3A5—endocrine gland—breast cancer	2.35e-05	0.00195	CbGeAlD
Paclitaxel—CYP2C9—endocrine gland—breast cancer	2.32e-05	0.00192	CbGeAlD
Paclitaxel—Cabazitaxel—ABCB1—breast cancer	2.24e-05	0.0243	CrCbGaD
Paclitaxel—Docetaxel—CYP3A4—breast cancer	2.17e-05	0.0236	CrCbGaD
Paclitaxel—ABCC1—lymph node—breast cancer	2.12e-05	0.00176	CbGeAlD
Paclitaxel—CYP3A4—female reproductive system—breast cancer	2.09e-05	0.00173	CbGeAlD
Paclitaxel—ABCB1—epithelium—breast cancer	1.99e-05	0.00165	CbGeAlD
Paclitaxel—TUBB6—Azacitidine—Gemcitabine—breast cancer	1.84e-05	0.0482	CbGdCrCtD
Paclitaxel—Docetaxel—ABCB1—breast cancer	1.81e-05	0.0196	CrCbGaD
Paclitaxel—ABCB1—endometrium—breast cancer	1.78e-05	0.00148	CbGeAlD
Paclitaxel—CYP3A4—endocrine gland—breast cancer	1.77e-05	0.00146	CbGeAlD
Paclitaxel—ABCG2—lymph node—breast cancer	1.75e-05	0.00145	CbGeAlD
Paclitaxel—ABCB1—uterus—breast cancer	1.64e-05	0.00136	CbGeAlD
Paclitaxel—ABCB1—pituitary gland—breast cancer	1.61e-05	0.00134	CbGeAlD
Paclitaxel—ABCB1—adipose tissue—breast cancer	1.61e-05	0.00133	CbGeAlD
Paclitaxel—ABCB1—female reproductive system—breast cancer	1.48e-05	0.00122	CbGeAlD
Paclitaxel—ABCB1—adrenal gland—breast cancer	1.44e-05	0.0012	CbGeAlD
Paclitaxel—ABCB1—bone marrow—breast cancer	1.39e-05	0.00116	CbGeAlD
Paclitaxel—ABCB1—female gonad—breast cancer	1.34e-05	0.00111	CbGeAlD
Paclitaxel—ABCB1—endocrine gland—breast cancer	1.25e-05	0.00104	CbGeAlD
Paclitaxel—ABCB1—lymph node—breast cancer	8.64e-06	0.000716	CbGeAlD
Paclitaxel—Headache—Fluorouracil—breast cancer	2.56e-06	6.68e-05	CcSEcCtD
Paclitaxel—Urinary tract disorder—Doxorubicin—breast cancer	2.56e-06	6.68e-05	CcSEcCtD
Paclitaxel—Oedema peripheral—Doxorubicin—breast cancer	2.55e-06	6.66e-05	CcSEcCtD
Paclitaxel—Dysgeusia—Methotrexate—breast cancer	2.55e-06	6.66e-05	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Docetaxel—breast cancer	2.54e-06	6.65e-05	CcSEcCtD
Paclitaxel—Connective tissue disorder—Doxorubicin—breast cancer	2.54e-06	6.65e-05	CcSEcCtD
Paclitaxel—Dyspnoea—Capecitabine—breast cancer	2.54e-06	6.65e-05	CcSEcCtD
Paclitaxel—Fatigue—Docetaxel—breast cancer	2.54e-06	6.64e-05	CcSEcCtD
Paclitaxel—Angiopathy—Epirubicin—breast cancer	2.54e-06	6.63e-05	CcSEcCtD
Paclitaxel—Urethral disorder—Doxorubicin—breast cancer	2.54e-06	6.63e-05	CcSEcCtD
Paclitaxel—Nausea—Mitoxantrone—breast cancer	2.53e-06	6.62e-05	CcSEcCtD
Paclitaxel—Nausea—Irinotecan—breast cancer	2.53e-06	6.62e-05	CcSEcCtD
Paclitaxel—Immune system disorder—Epirubicin—breast cancer	2.53e-06	6.6e-05	CcSEcCtD
Paclitaxel—Mediastinal disorder—Epirubicin—breast cancer	2.52e-06	6.59e-05	CcSEcCtD
Paclitaxel—Pain—Docetaxel—breast cancer	2.52e-06	6.59e-05	CcSEcCtD
Paclitaxel—Constipation—Docetaxel—breast cancer	2.52e-06	6.59e-05	CcSEcCtD
Paclitaxel—Back pain—Methotrexate—breast cancer	2.52e-06	6.58e-05	CcSEcCtD
Paclitaxel—Dyspepsia—Capecitabine—breast cancer	2.51e-06	6.56e-05	CcSEcCtD
Paclitaxel—Chills—Epirubicin—breast cancer	2.51e-06	6.56e-05	CcSEcCtD
Paclitaxel—Arrhythmia—Epirubicin—breast cancer	2.5e-06	6.53e-05	CcSEcCtD
Paclitaxel—Visual impairment—Doxorubicin—breast cancer	2.49e-06	6.52e-05	CcSEcCtD
Paclitaxel—Decreased appetite—Capecitabine—breast cancer	2.48e-06	6.48e-05	CcSEcCtD
Paclitaxel—Alopecia—Epirubicin—breast cancer	2.47e-06	6.46e-05	CcSEcCtD
Paclitaxel—Nausea—Gemcitabine—breast cancer	2.47e-06	6.45e-05	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Capecitabine—breast cancer	2.46e-06	6.44e-05	CcSEcCtD
Paclitaxel—Fatigue—Capecitabine—breast cancer	2.46e-06	6.43e-05	CcSEcCtD
Paclitaxel—Vision blurred—Methotrexate—breast cancer	2.45e-06	6.41e-05	CcSEcCtD
Paclitaxel—Mental disorder—Epirubicin—breast cancer	2.45e-06	6.41e-05	CcSEcCtD
Paclitaxel—Erythema multiforme—Doxorubicin—breast cancer	2.45e-06	6.4e-05	CcSEcCtD
Paclitaxel—Constipation—Capecitabine—breast cancer	2.44e-06	6.38e-05	CcSEcCtD
Paclitaxel—Pain—Capecitabine—breast cancer	2.44e-06	6.38e-05	CcSEcCtD
Paclitaxel—Erythema—Epirubicin—breast cancer	2.43e-06	6.36e-05	CcSEcCtD
Paclitaxel—Malnutrition—Epirubicin—breast cancer	2.43e-06	6.36e-05	CcSEcCtD
Paclitaxel—Feeling abnormal—Docetaxel—breast cancer	2.43e-06	6.35e-05	CcSEcCtD
Paclitaxel—Nausea—Fluorouracil—breast cancer	2.42e-06	6.34e-05	CcSEcCtD
Paclitaxel—Eye disorder—Doxorubicin—breast cancer	2.42e-06	6.32e-05	CcSEcCtD
Paclitaxel—Ill-defined disorder—Methotrexate—breast cancer	2.41e-06	6.31e-05	CcSEcCtD
Paclitaxel—Tinnitus—Doxorubicin—breast cancer	2.41e-06	6.31e-05	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Docetaxel—breast cancer	2.41e-06	6.3e-05	CcSEcCtD
Paclitaxel—Anaemia—Methotrexate—breast cancer	2.4e-06	6.29e-05	CcSEcCtD
Paclitaxel—Flushing—Doxorubicin—breast cancer	2.4e-06	6.28e-05	CcSEcCtD
Paclitaxel—Cardiac disorder—Doxorubicin—breast cancer	2.4e-06	6.28e-05	CcSEcCtD
Paclitaxel—Flatulence—Epirubicin—breast cancer	2.4e-06	6.27e-05	CcSEcCtD
Paclitaxel—Tension—Epirubicin—breast cancer	2.39e-06	6.25e-05	CcSEcCtD
Paclitaxel—Dysgeusia—Epirubicin—breast cancer	2.38e-06	6.23e-05	CcSEcCtD
Paclitaxel—Nervousness—Epirubicin—breast cancer	2.36e-06	6.18e-05	CcSEcCtD
Paclitaxel—Back pain—Epirubicin—breast cancer	2.35e-06	6.16e-05	CcSEcCtD
Paclitaxel—Feeling abnormal—Capecitabine—breast cancer	2.35e-06	6.14e-05	CcSEcCtD
Paclitaxel—Angiopathy—Doxorubicin—breast cancer	2.35e-06	6.14e-05	CcSEcCtD
Paclitaxel—Malaise—Methotrexate—breast cancer	2.35e-06	6.13e-05	CcSEcCtD
Paclitaxel—Muscle spasms—Epirubicin—breast cancer	2.34e-06	6.12e-05	CcSEcCtD
Paclitaxel—Immune system disorder—Doxorubicin—breast cancer	2.34e-06	6.11e-05	CcSEcCtD
Paclitaxel—Vertigo—Methotrexate—breast cancer	2.34e-06	6.11e-05	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Capecitabine—breast cancer	2.33e-06	6.1e-05	CcSEcCtD
Paclitaxel—Mediastinal disorder—Doxorubicin—breast cancer	2.33e-06	6.1e-05	CcSEcCtD
Paclitaxel—Body temperature increased—Docetaxel—breast cancer	2.33e-06	6.09e-05	CcSEcCtD
Paclitaxel—Abdominal pain—Docetaxel—breast cancer	2.33e-06	6.09e-05	CcSEcCtD
Paclitaxel—Leukopenia—Methotrexate—breast cancer	2.33e-06	6.09e-05	CcSEcCtD
Paclitaxel—Chills—Doxorubicin—breast cancer	2.32e-06	6.07e-05	CcSEcCtD
Paclitaxel—Arrhythmia—Doxorubicin—breast cancer	2.31e-06	6.04e-05	CcSEcCtD
Paclitaxel—Vision blurred—Epirubicin—breast cancer	2.29e-06	6e-05	CcSEcCtD
Paclitaxel—Alopecia—Doxorubicin—breast cancer	2.29e-06	5.98e-05	CcSEcCtD
Paclitaxel—Cough—Methotrexate—breast cancer	2.27e-06	5.93e-05	CcSEcCtD
Paclitaxel—Mental disorder—Doxorubicin—breast cancer	2.27e-06	5.93e-05	CcSEcCtD
Paclitaxel—Urticaria—Capecitabine—breast cancer	2.27e-06	5.92e-05	CcSEcCtD
Paclitaxel—Ill-defined disorder—Epirubicin—breast cancer	2.26e-06	5.91e-05	CcSEcCtD
Paclitaxel—Abdominal pain—Capecitabine—breast cancer	2.25e-06	5.89e-05	CcSEcCtD
Paclitaxel—Body temperature increased—Capecitabine—breast cancer	2.25e-06	5.89e-05	CcSEcCtD
Paclitaxel—Convulsion—Methotrexate—breast cancer	2.25e-06	5.89e-05	CcSEcCtD
Paclitaxel—Malnutrition—Doxorubicin—breast cancer	2.25e-06	5.89e-05	CcSEcCtD
Paclitaxel—Erythema—Doxorubicin—breast cancer	2.25e-06	5.89e-05	CcSEcCtD
Paclitaxel—Anaemia—Epirubicin—breast cancer	2.25e-06	5.88e-05	CcSEcCtD
Paclitaxel—Agitation—Epirubicin—breast cancer	2.24e-06	5.85e-05	CcSEcCtD
Paclitaxel—Flatulence—Doxorubicin—breast cancer	2.22e-06	5.8e-05	CcSEcCtD
Paclitaxel—Chest pain—Methotrexate—breast cancer	2.21e-06	5.79e-05	CcSEcCtD
Paclitaxel—Myalgia—Methotrexate—breast cancer	2.21e-06	5.79e-05	CcSEcCtD
Paclitaxel—Arthralgia—Methotrexate—breast cancer	2.21e-06	5.79e-05	CcSEcCtD
Paclitaxel—Tension—Doxorubicin—breast cancer	2.21e-06	5.78e-05	CcSEcCtD
Paclitaxel—Dysgeusia—Doxorubicin—breast cancer	2.21e-06	5.77e-05	CcSEcCtD
Paclitaxel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	2.2e-06	5.75e-05	CcSEcCtD
Paclitaxel—Malaise—Epirubicin—breast cancer	2.2e-06	5.74e-05	CcSEcCtD
Paclitaxel—Discomfort—Methotrexate—breast cancer	2.19e-06	5.72e-05	CcSEcCtD
Paclitaxel—Nervousness—Doxorubicin—breast cancer	2.19e-06	5.72e-05	CcSEcCtD
Paclitaxel—Vertigo—Epirubicin—breast cancer	2.19e-06	5.72e-05	CcSEcCtD
Paclitaxel—Syncope—Epirubicin—breast cancer	2.18e-06	5.71e-05	CcSEcCtD
Paclitaxel—Leukopenia—Epirubicin—breast cancer	2.18e-06	5.7e-05	CcSEcCtD
Paclitaxel—Back pain—Doxorubicin—breast cancer	2.18e-06	5.7e-05	CcSEcCtD
Paclitaxel—Hypersensitivity—Docetaxel—breast cancer	2.17e-06	5.67e-05	CcSEcCtD
Paclitaxel—Muscle spasms—Doxorubicin—breast cancer	2.17e-06	5.66e-05	CcSEcCtD
Paclitaxel—Palpitations—Epirubicin—breast cancer	2.15e-06	5.62e-05	CcSEcCtD
Paclitaxel—Confusional state—Methotrexate—breast cancer	2.14e-06	5.6e-05	CcSEcCtD
Paclitaxel—Loss of consciousness—Epirubicin—breast cancer	2.14e-06	5.59e-05	CcSEcCtD
Paclitaxel—Cough—Epirubicin—breast cancer	2.12e-06	5.55e-05	CcSEcCtD
Paclitaxel—Anaphylactic shock—Methotrexate—breast cancer	2.12e-06	5.55e-05	CcSEcCtD
Paclitaxel—Vision blurred—Doxorubicin—breast cancer	2.12e-06	5.55e-05	CcSEcCtD
Paclitaxel—Asthenia—Docetaxel—breast cancer	2.11e-06	5.53e-05	CcSEcCtD
Paclitaxel—Convulsion—Epirubicin—breast cancer	2.11e-06	5.51e-05	CcSEcCtD
Paclitaxel—Infection—Methotrexate—breast cancer	2.11e-06	5.51e-05	CcSEcCtD
Paclitaxel—Hypertension—Epirubicin—breast cancer	2.1e-06	5.49e-05	CcSEcCtD
Paclitaxel—Hypersensitivity—Capecitabine—breast cancer	2.1e-06	5.49e-05	CcSEcCtD
Paclitaxel—Ill-defined disorder—Doxorubicin—breast cancer	2.09e-06	5.46e-05	CcSEcCtD
Paclitaxel—Pruritus—Docetaxel—breast cancer	2.08e-06	5.45e-05	CcSEcCtD
Paclitaxel—Nervous system disorder—Methotrexate—breast cancer	2.08e-06	5.44e-05	CcSEcCtD
Paclitaxel—Anaemia—Doxorubicin—breast cancer	2.08e-06	5.44e-05	CcSEcCtD
Paclitaxel—Thrombocytopenia—Methotrexate—breast cancer	2.08e-06	5.43e-05	CcSEcCtD
Paclitaxel—Myalgia—Epirubicin—breast cancer	2.07e-06	5.42e-05	CcSEcCtD
Paclitaxel—Arthralgia—Epirubicin—breast cancer	2.07e-06	5.42e-05	CcSEcCtD
Paclitaxel—Chest pain—Epirubicin—breast cancer	2.07e-06	5.42e-05	CcSEcCtD
Paclitaxel—Agitation—Doxorubicin—breast cancer	2.07e-06	5.41e-05	CcSEcCtD
Paclitaxel—Anxiety—Epirubicin—breast cancer	2.07e-06	5.4e-05	CcSEcCtD
Paclitaxel—Skin disorder—Methotrexate—breast cancer	2.06e-06	5.39e-05	CcSEcCtD
Paclitaxel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	2.06e-06	5.38e-05	CcSEcCtD
Paclitaxel—Hyperhidrosis—Methotrexate—breast cancer	2.05e-06	5.37e-05	CcSEcCtD
Paclitaxel—Discomfort—Epirubicin—breast cancer	2.05e-06	5.35e-05	CcSEcCtD
Paclitaxel—Asthenia—Capecitabine—breast cancer	2.05e-06	5.35e-05	CcSEcCtD
Paclitaxel—Malaise—Doxorubicin—breast cancer	2.03e-06	5.31e-05	CcSEcCtD
Paclitaxel—Dry mouth—Epirubicin—breast cancer	2.03e-06	5.3e-05	CcSEcCtD
Paclitaxel—Vertigo—Doxorubicin—breast cancer	2.02e-06	5.29e-05	CcSEcCtD
Paclitaxel—Anorexia—Methotrexate—breast cancer	2.02e-06	5.29e-05	CcSEcCtD
Paclitaxel—Syncope—Doxorubicin—breast cancer	2.02e-06	5.28e-05	CcSEcCtD
Paclitaxel—Pruritus—Capecitabine—breast cancer	2.02e-06	5.28e-05	CcSEcCtD
Paclitaxel—Leukopenia—Doxorubicin—breast cancer	2.02e-06	5.27e-05	CcSEcCtD
Paclitaxel—Diarrhoea—Docetaxel—breast cancer	2.02e-06	5.27e-05	CcSEcCtD
Paclitaxel—Confusional state—Epirubicin—breast cancer	2e-06	5.24e-05	CcSEcCtD
Paclitaxel—Palpitations—Doxorubicin—breast cancer	1.99e-06	5.2e-05	CcSEcCtD
Paclitaxel—Oedema—Epirubicin—breast cancer	1.99e-06	5.19e-05	CcSEcCtD
Paclitaxel—Anaphylactic shock—Epirubicin—breast cancer	1.99e-06	5.19e-05	CcSEcCtD
Paclitaxel—Hypotension—Methotrexate—breast cancer	1.98e-06	5.19e-05	CcSEcCtD
Paclitaxel—Loss of consciousness—Doxorubicin—breast cancer	1.98e-06	5.18e-05	CcSEcCtD
Paclitaxel—Infection—Epirubicin—breast cancer	1.97e-06	5.16e-05	CcSEcCtD
Paclitaxel—Cough—Doxorubicin—breast cancer	1.97e-06	5.14e-05	CcSEcCtD
Paclitaxel—Shock—Epirubicin—breast cancer	1.95e-06	5.11e-05	CcSEcCtD
Paclitaxel—Convulsion—Doxorubicin—breast cancer	1.95e-06	5.1e-05	CcSEcCtD
Paclitaxel—Diarrhoea—Capecitabine—breast cancer	1.95e-06	5.1e-05	CcSEcCtD
Paclitaxel—Nervous system disorder—Epirubicin—breast cancer	1.95e-06	5.09e-05	CcSEcCtD
Paclitaxel—Dizziness—Docetaxel—breast cancer	1.95e-06	5.09e-05	CcSEcCtD
Paclitaxel—Thrombocytopenia—Epirubicin—breast cancer	1.95e-06	5.09e-05	CcSEcCtD
Paclitaxel—Hypertension—Doxorubicin—breast cancer	1.94e-06	5.08e-05	CcSEcCtD
Paclitaxel—Tachycardia—Epirubicin—breast cancer	1.94e-06	5.07e-05	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Methotrexate—breast cancer	1.93e-06	5.06e-05	CcSEcCtD
Paclitaxel—Skin disorder—Epirubicin—breast cancer	1.93e-06	5.05e-05	CcSEcCtD
Paclitaxel—Hyperhidrosis—Epirubicin—breast cancer	1.92e-06	5.02e-05	CcSEcCtD
Paclitaxel—Insomnia—Methotrexate—breast cancer	1.92e-06	5.02e-05	CcSEcCtD
Paclitaxel—Myalgia—Doxorubicin—breast cancer	1.92e-06	5.01e-05	CcSEcCtD
Paclitaxel—Chest pain—Doxorubicin—breast cancer	1.92e-06	5.01e-05	CcSEcCtD
Paclitaxel—Arthralgia—Doxorubicin—breast cancer	1.92e-06	5.01e-05	CcSEcCtD
Paclitaxel—Anxiety—Doxorubicin—breast cancer	1.91e-06	5e-05	CcSEcCtD
Paclitaxel—Paraesthesia—Methotrexate—breast cancer	1.91e-06	4.98e-05	CcSEcCtD
Paclitaxel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	1.9e-06	4.98e-05	CcSEcCtD
Paclitaxel—Discomfort—Doxorubicin—breast cancer	1.89e-06	4.95e-05	CcSEcCtD
Paclitaxel—Anorexia—Epirubicin—breast cancer	1.89e-06	4.95e-05	CcSEcCtD
Paclitaxel—Dyspnoea—Methotrexate—breast cancer	1.89e-06	4.95e-05	CcSEcCtD
Paclitaxel—Somnolence—Methotrexate—breast cancer	1.89e-06	4.93e-05	CcSEcCtD
Paclitaxel—Dizziness—Capecitabine—breast cancer	1.89e-06	4.93e-05	CcSEcCtD
Paclitaxel—Dry mouth—Doxorubicin—breast cancer	1.88e-06	4.9e-05	CcSEcCtD
Paclitaxel—Vomiting—Docetaxel—breast cancer	1.87e-06	4.9e-05	CcSEcCtD
Paclitaxel—Dyspepsia—Methotrexate—breast cancer	1.87e-06	4.89e-05	CcSEcCtD
Paclitaxel—Rash—Docetaxel—breast cancer	1.86e-06	4.86e-05	CcSEcCtD
Paclitaxel—Hypotension—Epirubicin—breast cancer	1.86e-06	4.85e-05	CcSEcCtD
Paclitaxel—Dermatitis—Docetaxel—breast cancer	1.86e-06	4.85e-05	CcSEcCtD
Paclitaxel—Confusional state—Doxorubicin—breast cancer	1.85e-06	4.85e-05	CcSEcCtD
Paclitaxel—Decreased appetite—Methotrexate—breast cancer	1.85e-06	4.82e-05	CcSEcCtD
Paclitaxel—Headache—Docetaxel—breast cancer	1.85e-06	4.82e-05	CcSEcCtD
Paclitaxel—Anaphylactic shock—Doxorubicin—breast cancer	1.84e-06	4.81e-05	CcSEcCtD
Paclitaxel—Oedema—Doxorubicin—breast cancer	1.84e-06	4.81e-05	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Methotrexate—breast cancer	1.83e-06	4.79e-05	CcSEcCtD
Paclitaxel—Fatigue—Methotrexate—breast cancer	1.83e-06	4.79e-05	CcSEcCtD
Paclitaxel—Infection—Doxorubicin—breast cancer	1.83e-06	4.77e-05	CcSEcCtD
Paclitaxel—Pain—Methotrexate—breast cancer	1.82e-06	4.75e-05	CcSEcCtD
Paclitaxel—Vomiting—Capecitabine—breast cancer	1.81e-06	4.74e-05	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Epirubicin—breast cancer	1.81e-06	4.73e-05	CcSEcCtD
Paclitaxel—Shock—Doxorubicin—breast cancer	1.81e-06	4.73e-05	CcSEcCtD
Paclitaxel—Nervous system disorder—Doxorubicin—breast cancer	1.8e-06	4.71e-05	CcSEcCtD
Paclitaxel—Thrombocytopenia—Doxorubicin—breast cancer	1.8e-06	4.71e-05	CcSEcCtD
Paclitaxel—Rash—Capecitabine—breast cancer	1.8e-06	4.7e-05	CcSEcCtD
Paclitaxel—Insomnia—Epirubicin—breast cancer	1.8e-06	4.7e-05	CcSEcCtD
Paclitaxel—Dermatitis—Capecitabine—breast cancer	1.8e-06	4.7e-05	CcSEcCtD
Paclitaxel—Tachycardia—Doxorubicin—breast cancer	1.79e-06	4.69e-05	CcSEcCtD
Paclitaxel—Headache—Capecitabine—breast cancer	1.79e-06	4.67e-05	CcSEcCtD
Paclitaxel—Skin disorder—Doxorubicin—breast cancer	1.79e-06	4.67e-05	CcSEcCtD
Paclitaxel—Paraesthesia—Epirubicin—breast cancer	1.78e-06	4.66e-05	CcSEcCtD
Paclitaxel—Hyperhidrosis—Doxorubicin—breast cancer	1.78e-06	4.65e-05	CcSEcCtD
Paclitaxel—Dyspnoea—Epirubicin—breast cancer	1.77e-06	4.63e-05	CcSEcCtD
Paclitaxel—Somnolence—Epirubicin—breast cancer	1.77e-06	4.62e-05	CcSEcCtD
Paclitaxel—Anorexia—Doxorubicin—breast cancer	1.75e-06	4.58e-05	CcSEcCtD
Paclitaxel—Nausea—Docetaxel—breast cancer	1.75e-06	4.57e-05	CcSEcCtD
Paclitaxel—Feeling abnormal—Methotrexate—breast cancer	1.75e-06	4.57e-05	CcSEcCtD
Paclitaxel—Dyspepsia—Epirubicin—breast cancer	1.75e-06	4.57e-05	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Methotrexate—breast cancer	1.74e-06	4.54e-05	CcSEcCtD
Paclitaxel—Decreased appetite—Epirubicin—breast cancer	1.73e-06	4.52e-05	CcSEcCtD
Paclitaxel—Hypotension—Doxorubicin—breast cancer	1.72e-06	4.49e-05	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Epirubicin—breast cancer	1.72e-06	4.48e-05	CcSEcCtD
Paclitaxel—Fatigue—Epirubicin—breast cancer	1.71e-06	4.48e-05	CcSEcCtD
Paclitaxel—Pain—Epirubicin—breast cancer	1.7e-06	4.44e-05	CcSEcCtD
Paclitaxel—Constipation—Epirubicin—breast cancer	1.7e-06	4.44e-05	CcSEcCtD
Paclitaxel—Nausea—Capecitabine—breast cancer	1.69e-06	4.43e-05	CcSEcCtD
Paclitaxel—Urticaria—Methotrexate—breast cancer	1.69e-06	4.41e-05	CcSEcCtD
Paclitaxel—Abdominal pain—Methotrexate—breast cancer	1.68e-06	4.39e-05	CcSEcCtD
Paclitaxel—Body temperature increased—Methotrexate—breast cancer	1.68e-06	4.39e-05	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Doxorubicin—breast cancer	1.67e-06	4.38e-05	CcSEcCtD
Paclitaxel—Insomnia—Doxorubicin—breast cancer	1.66e-06	4.35e-05	CcSEcCtD
Paclitaxel—Paraesthesia—Doxorubicin—breast cancer	1.65e-06	4.32e-05	CcSEcCtD
Paclitaxel—Dyspnoea—Doxorubicin—breast cancer	1.64e-06	4.28e-05	CcSEcCtD
Paclitaxel—Feeling abnormal—Epirubicin—breast cancer	1.64e-06	4.28e-05	CcSEcCtD
Paclitaxel—Somnolence—Doxorubicin—breast cancer	1.63e-06	4.27e-05	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Epirubicin—breast cancer	1.62e-06	4.25e-05	CcSEcCtD
Paclitaxel—Dyspepsia—Doxorubicin—breast cancer	1.62e-06	4.23e-05	CcSEcCtD
Paclitaxel—Decreased appetite—Doxorubicin—breast cancer	1.6e-06	4.18e-05	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Doxorubicin—breast cancer	1.59e-06	4.15e-05	CcSEcCtD
Paclitaxel—Fatigue—Doxorubicin—breast cancer	1.58e-06	4.14e-05	CcSEcCtD
Paclitaxel—Urticaria—Epirubicin—breast cancer	1.58e-06	4.13e-05	CcSEcCtD
Paclitaxel—Pain—Doxorubicin—breast cancer	1.57e-06	4.11e-05	CcSEcCtD
Paclitaxel—Constipation—Doxorubicin—breast cancer	1.57e-06	4.11e-05	CcSEcCtD
Paclitaxel—Abdominal pain—Epirubicin—breast cancer	1.57e-06	4.11e-05	CcSEcCtD
Paclitaxel—Body temperature increased—Epirubicin—breast cancer	1.57e-06	4.11e-05	CcSEcCtD
Paclitaxel—Hypersensitivity—Methotrexate—breast cancer	1.56e-06	4.09e-05	CcSEcCtD
Paclitaxel—Asthenia—Methotrexate—breast cancer	1.52e-06	3.98e-05	CcSEcCtD
Paclitaxel—Feeling abnormal—Doxorubicin—breast cancer	1.51e-06	3.96e-05	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Doxorubicin—breast cancer	1.5e-06	3.93e-05	CcSEcCtD
Paclitaxel—Pruritus—Methotrexate—breast cancer	1.5e-06	3.93e-05	CcSEcCtD
Paclitaxel—Hypersensitivity—Epirubicin—breast cancer	1.46e-06	3.83e-05	CcSEcCtD
Paclitaxel—Urticaria—Doxorubicin—breast cancer	1.46e-06	3.82e-05	CcSEcCtD
Paclitaxel—Abdominal pain—Doxorubicin—breast cancer	1.45e-06	3.8e-05	CcSEcCtD
Paclitaxel—Body temperature increased—Doxorubicin—breast cancer	1.45e-06	3.8e-05	CcSEcCtD
Paclitaxel—Diarrhoea—Methotrexate—breast cancer	1.45e-06	3.8e-05	CcSEcCtD
Paclitaxel—Asthenia—Epirubicin—breast cancer	1.43e-06	3.73e-05	CcSEcCtD
Paclitaxel—Pruritus—Epirubicin—breast cancer	1.41e-06	3.67e-05	CcSEcCtD
Paclitaxel—Dizziness—Methotrexate—breast cancer	1.4e-06	3.67e-05	CcSEcCtD
Paclitaxel—Diarrhoea—Epirubicin—breast cancer	1.36e-06	3.55e-05	CcSEcCtD
Paclitaxel—Hypersensitivity—Doxorubicin—breast cancer	1.35e-06	3.54e-05	CcSEcCtD
Paclitaxel—Vomiting—Methotrexate—breast cancer	1.35e-06	3.53e-05	CcSEcCtD
Paclitaxel—Rash—Methotrexate—breast cancer	1.34e-06	3.5e-05	CcSEcCtD
Paclitaxel—Dermatitis—Methotrexate—breast cancer	1.34e-06	3.5e-05	CcSEcCtD
Paclitaxel—Headache—Methotrexate—breast cancer	1.33e-06	3.48e-05	CcSEcCtD
Paclitaxel—Asthenia—Doxorubicin—breast cancer	1.32e-06	3.45e-05	CcSEcCtD
Paclitaxel—Dizziness—Epirubicin—breast cancer	1.31e-06	3.43e-05	CcSEcCtD
Paclitaxel—Pruritus—Doxorubicin—breast cancer	1.3e-06	3.4e-05	CcSEcCtD
Paclitaxel—Vomiting—Epirubicin—breast cancer	1.26e-06	3.3e-05	CcSEcCtD
Paclitaxel—Nausea—Methotrexate—breast cancer	1.26e-06	3.3e-05	CcSEcCtD
Paclitaxel—Diarrhoea—Doxorubicin—breast cancer	1.26e-06	3.29e-05	CcSEcCtD
Paclitaxel—Rash—Epirubicin—breast cancer	1.25e-06	3.28e-05	CcSEcCtD
Paclitaxel—Dermatitis—Epirubicin—breast cancer	1.25e-06	3.27e-05	CcSEcCtD
Paclitaxel—Headache—Epirubicin—breast cancer	1.24e-06	3.25e-05	CcSEcCtD
Paclitaxel—Dizziness—Doxorubicin—breast cancer	1.22e-06	3.18e-05	CcSEcCtD
Paclitaxel—Nausea—Epirubicin—breast cancer	1.18e-06	3.09e-05	CcSEcCtD
Paclitaxel—Vomiting—Doxorubicin—breast cancer	1.17e-06	3.06e-05	CcSEcCtD
Paclitaxel—Rash—Doxorubicin—breast cancer	1.16e-06	3.03e-05	CcSEcCtD
Paclitaxel—Dermatitis—Doxorubicin—breast cancer	1.16e-06	3.03e-05	CcSEcCtD
Paclitaxel—Headache—Doxorubicin—breast cancer	1.15e-06	3.01e-05	CcSEcCtD
Paclitaxel—Nausea—Doxorubicin—breast cancer	1.09e-06	2.85e-05	CcSEcCtD
Paclitaxel—CYP2C9—Metabolism—CYP17A1—breast cancer	2.4e-07	9.25e-06	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PIK3CD—breast cancer	2.38e-07	9.18e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Transmembrane transport of small molecules—ALB—breast cancer	2.38e-07	9.17e-06	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—PTEN—breast cancer	2.38e-07	9.17e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—ENO1—breast cancer	2.38e-07	9.16e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PTGS1—breast cancer	2.38e-07	9.16e-06	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PIK3CG—breast cancer	2.38e-07	9.15e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—FASN—breast cancer	2.38e-07	9.15e-06	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PIK3CD—breast cancer	2.37e-07	9.14e-06	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—NCOA1—breast cancer	2.37e-07	9.13e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	2.37e-07	9.12e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—BCHE—breast cancer	2.37e-07	9.11e-06	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—ABCB1—breast cancer	2.36e-07	9.1e-06	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PIK3CG—breast cancer	2.36e-07	9.07e-06	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—ALB—breast cancer	2.35e-07	9.06e-06	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—ALB—breast cancer	2.34e-07	9.03e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—ALB—breast cancer	2.34e-07	9.01e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—SLC5A5—breast cancer	2.34e-07	9e-06	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—STK11—breast cancer	2.34e-07	8.99e-06	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—CYP19A1—breast cancer	2.34e-07	8.99e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CYP2D6—breast cancer	2.33e-07	8.98e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—GSTA4—breast cancer	2.32e-07	8.94e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CA9—breast cancer	2.32e-07	8.94e-06	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—TYMS—breast cancer	2.32e-07	8.93e-06	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—CDKN1B—breast cancer	2.32e-07	8.93e-06	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—IL6—breast cancer	2.3e-07	8.87e-06	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PIK3CD—breast cancer	2.3e-07	8.84e-06	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PLA2G4A—breast cancer	2.29e-07	8.83e-06	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—NCOR1—breast cancer	2.29e-07	8.83e-06	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—GSTM1—breast cancer	2.29e-07	8.83e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—NCOA2—breast cancer	2.29e-07	8.81e-06	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—ALB—breast cancer	2.27e-07	8.73e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—GPX2—breast cancer	2.26e-07	8.71e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—GSTA2—breast cancer	2.26e-07	8.71e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—SLC2A1—breast cancer	2.26e-07	8.69e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—NQO1—breast cancer	2.26e-07	8.69e-06	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—NOS3—breast cancer	2.25e-07	8.67e-06	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—NOS3—breast cancer	2.24e-07	8.63e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—SULT1A1—breast cancer	2.23e-07	8.61e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—GPX4—breast cancer	2.23e-07	8.61e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—FASN—breast cancer	2.22e-07	8.55e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—BCHE—breast cancer	2.21e-07	8.51e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—CYP3A4—breast cancer	2.2e-07	8.48e-06	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—GPX1—breast cancer	2.2e-07	8.46e-06	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.19e-07	8.44e-06	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—CTNNB1—breast cancer	2.19e-07	8.44e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—SLC5A5—breast cancer	2.18e-07	8.41e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—GSTA1—breast cancer	2.18e-07	8.41e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—IDH1—breast cancer	2.18e-07	8.41e-06	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—CYP1A1—breast cancer	2.17e-07	8.37e-06	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—COMT—breast cancer	2.17e-07	8.36e-06	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—NOS3—breast cancer	2.17e-07	8.35e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—CYP1B1—breast cancer	2.16e-07	8.33e-06	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—GSTP1—breast cancer	2.16e-07	8.32e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—NAT2—breast cancer	2.16e-07	8.31e-06	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—ERCC2—breast cancer	2.16e-07	8.3e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	2.15e-07	8.29e-06	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—CDKN1A—breast cancer	2.14e-07	8.24e-06	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—PTEN—breast cancer	2.14e-07	8.22e-06	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—HMOX1—breast cancer	2.13e-07	8.21e-06	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—ITPR1—breast cancer	2.13e-07	8.19e-06	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—AKT1—breast cancer	2.12e-07	8.18e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—HSP90AA1—breast cancer	2.12e-07	8.17e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—NQO1—breast cancer	2.11e-07	8.12e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—SLC2A1—breast cancer	2.11e-07	8.12e-06	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PIK3CD—breast cancer	2.09e-07	8.04e-06	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PIK3CB—breast cancer	2.08e-07	8e-06	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PIK3CD—breast cancer	2.07e-07	7.97e-06	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PIK3CB—breast cancer	2.07e-07	7.97e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	2.07e-07	7.95e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—NCOA1—breast cancer	2.06e-07	7.95e-06	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—ALB—breast cancer	2.06e-07	7.94e-06	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PTGS2—breast cancer	2.06e-07	7.93e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CYP3A4—breast cancer	2.06e-07	7.92e-06	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PTGS2—breast cancer	2.05e-07	7.9e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	2.05e-07	7.88e-06	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—ABCB1—breast cancer	2.05e-07	7.88e-06	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—ALB—breast cancer	2.04e-07	7.87e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—STK11—breast cancer	2.03e-07	7.84e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—CYP19A1—breast cancer	2.03e-07	7.84e-06	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—MTHFR—breast cancer	2.03e-07	7.8e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CYP1B1—breast cancer	2.02e-07	7.79e-06	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—TYMS—breast cancer	2.01e-07	7.74e-06	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PIK3CB—breast cancer	2e-07	7.71e-06	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PLA2G4A—breast cancer	1.99e-07	7.65e-06	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—GSTM1—breast cancer	1.99e-07	7.65e-06	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—NCOR1—breast cancer	1.99e-07	7.65e-06	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PTGS2—breast cancer	1.98e-07	7.64e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—HSP90AA1—breast cancer	1.98e-07	7.64e-06	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—SRC—breast cancer	1.98e-07	7.63e-06	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—NOS3—breast cancer	1.97e-07	7.6e-06	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—NOS3—breast cancer	1.96e-07	7.53e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—NCOA1—breast cancer	1.93e-07	7.43e-06	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—STAT3—breast cancer	1.91e-07	7.35e-06	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—GPX1—breast cancer	1.9e-07	7.32e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—STK11—breast cancer	1.9e-07	7.32e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CYP19A1—breast cancer	1.9e-07	7.32e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—DPYD—breast cancer	1.89e-07	7.29e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—MED12—breast cancer	1.89e-07	7.29e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—COMT—breast cancer	1.89e-07	7.29e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—GSTP1—breast cancer	1.88e-07	7.25e-06	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—CYP1A1—breast cancer	1.88e-07	7.25e-06	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—CAV1—breast cancer	1.87e-07	7.2e-06	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—ERCC2—breast cancer	1.87e-07	7.19e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ALDOA—breast cancer	1.86e-07	7.17e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—HMOX1—breast cancer	1.86e-07	7.15e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—ITPR1—breast cancer	1.85e-07	7.13e-06	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—MAPK3—breast cancer	1.82e-07	7.03e-06	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PIK3CB—breast cancer	1.82e-07	7.01e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—NCOA3—breast cancer	1.81e-07	6.97e-06	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PIK3CB—breast cancer	1.8e-07	6.95e-06	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PTGS2—breast cancer	1.8e-07	6.95e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—SLC2A2—breast cancer	1.8e-07	6.92e-06	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PTEN—breast cancer	1.8e-07	6.92e-06	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PTGS2—breast cancer	1.79e-07	6.89e-06	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PTEN—breast cancer	1.79e-07	6.89e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.78e-07	6.87e-06	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—PIK3CA—breast cancer	1.78e-07	6.87e-06	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—MYC—breast cancer	1.77e-07	6.83e-06	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—TGFB1—breast cancer	1.77e-07	6.82e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—COMT—breast cancer	1.77e-07	6.81e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—MTR—breast cancer	1.76e-07	6.78e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CPT1A—breast cancer	1.76e-07	6.78e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ABCG2—breast cancer	1.76e-07	6.78e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—GSTP1—breast cancer	1.76e-07	6.77e-06	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—MTHFR—breast cancer	1.76e-07	6.76e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—TYMS—breast cancer	1.75e-07	6.74e-06	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—EGFR—breast cancer	1.74e-07	6.68e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—HMOX1—breast cancer	1.73e-07	6.68e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—ITPR1—breast cancer	1.73e-07	6.67e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—NCOR1—breast cancer	1.73e-07	6.66e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PLA2G4A—breast cancer	1.73e-07	6.66e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—GSTM1—breast cancer	1.73e-07	6.66e-06	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PTEN—breast cancer	1.73e-07	6.66e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—HPGDS—breast cancer	1.73e-07	6.64e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—HBA1—breast cancer	1.71e-07	6.6e-06	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PIK3CG—breast cancer	1.7e-07	6.56e-06	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—PIK3CA—breast cancer	1.68e-07	6.47e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ACHE—breast cancer	1.67e-07	6.44e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—GSTT1—breast cancer	1.67e-07	6.44e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—ABCB1—breast cancer	1.67e-07	6.41e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—GPX1—breast cancer	1.66e-07	6.38e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—CYP1A1—breast cancer	1.64e-07	6.32e-06	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—KRAS—breast cancer	1.64e-07	6.31e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—TYMS—breast cancer	1.64e-07	6.3e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—ERCC2—breast cancer	1.63e-07	6.26e-06	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—CAV1—breast cancer	1.62e-07	6.23e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PLA2G4A—breast cancer	1.62e-07	6.22e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—GSTM1—breast cancer	1.62e-07	6.22e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—NCOR1—breast cancer	1.62e-07	6.22e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CYP17A1—breast cancer	1.58e-07	6.1e-06	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PTEN—breast cancer	1.57e-07	6.06e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ENO1—breast cancer	1.57e-07	6.04e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PTGS1—breast cancer	1.57e-07	6.04e-06	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PTEN—breast cancer	1.56e-07	6.01e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—GPX1—breast cancer	1.55e-07	5.96e-06	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.55e-07	5.96e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CYP2D6—breast cancer	1.54e-07	5.92e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CYP1A1—breast cancer	1.53e-07	5.9e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—MTHFR—breast cancer	1.53e-07	5.89e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—ERCC2—breast cancer	1.52e-07	5.85e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—NCOA2—breast cancer	1.51e-07	5.81e-06	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—PIK3CA—breast cancer	1.51e-07	5.8e-06	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PIK3CD—breast cancer	1.5e-07	5.76e-06	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—ALB—breast cancer	1.48e-07	5.69e-06	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PIK3CG—breast cancer	1.47e-07	5.68e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—FASN—breast cancer	1.46e-07	5.64e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—BCHE—breast cancer	1.46e-07	5.61e-06	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—AKT1—breast cancer	1.46e-07	5.61e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—SLC5A5—breast cancer	1.44e-07	5.55e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—MTHFR—breast cancer	1.43e-07	5.5e-06	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—NOS3—breast cancer	1.41e-07	5.44e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—CAV1—breast cancer	1.41e-07	5.43e-06	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—HRAS—breast cancer	1.39e-07	5.37e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—NQO1—breast cancer	1.39e-07	5.36e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—SLC2A1—breast cancer	1.39e-07	5.36e-06	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—AKT1—breast cancer	1.37e-07	5.28e-06	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—IL6—breast cancer	1.33e-07	5.14e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CYP1B1—breast cancer	1.33e-07	5.14e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CAV1—breast cancer	1.32e-07	5.07e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—HSP90AA1—breast cancer	1.31e-07	5.04e-06	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PIK3CB—breast cancer	1.3e-07	5.02e-06	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PIK3CD—breast cancer	1.3e-07	4.99e-06	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PTGS2—breast cancer	1.29e-07	4.98e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PIK3CG—breast cancer	1.28e-07	4.95e-06	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—ALB—breast cancer	1.28e-07	4.93e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—NCOA1—breast cancer	1.27e-07	4.9e-06	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PIK3CA—breast cancer	1.27e-07	4.88e-06	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PIK3CA—breast cancer	1.26e-07	4.86e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.26e-07	4.85e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CYP19A1—breast cancer	1.25e-07	4.83e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—STK11—breast cancer	1.25e-07	4.83e-06	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—AKT1—breast cancer	1.23e-07	4.74e-06	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—NOS3—breast cancer	1.22e-07	4.71e-06	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PIK3CA—breast cancer	1.22e-07	4.7e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PIK3CG—breast cancer	1.2e-07	4.62e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—COMT—breast cancer	1.17e-07	4.49e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—GSTP1—breast cancer	1.16e-07	4.47e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—HMOX1—breast cancer	1.14e-07	4.41e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ITPR1—breast cancer	1.14e-07	4.4e-06	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PIK3CB—breast cancer	1.13e-07	4.35e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PIK3CD—breast cancer	1.13e-07	4.35e-06	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PTEN—breast cancer	1.13e-07	4.34e-06	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PTGS2—breast cancer	1.12e-07	4.31e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—ALB—breast cancer	1.11e-07	4.29e-06	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PIK3CA—breast cancer	1.11e-07	4.27e-06	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PIK3CA—breast cancer	1.1e-07	4.24e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ABCB1—breast cancer	1.1e-07	4.23e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—TYMS—breast cancer	1.08e-07	4.15e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—NOS3—breast cancer	1.07e-07	4.11e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.07e-07	4.11e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—NCOR1—breast cancer	1.07e-07	4.11e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—GSTM1—breast cancer	1.07e-07	4.11e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PIK3CD—breast cancer	1.06e-07	4.06e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—ALB—breast cancer	1.04e-07	4.01e-06	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—AKT1—breast cancer	1.04e-07	3.99e-06	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—AKT1—breast cancer	1.03e-07	3.97e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—GPX1—breast cancer	1.02e-07	3.93e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CYP1A1—breast cancer	1.01e-07	3.89e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ERCC2—breast cancer	1e-07	3.86e-06	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—AKT1—breast cancer	9.97e-08	3.84e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—NOS3—breast cancer	9.96e-08	3.84e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PIK3CB—breast cancer	9.84e-08	3.79e-06	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PTEN—breast cancer	9.76e-08	3.76e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PTGS2—breast cancer	9.75e-08	3.76e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—MTHFR—breast cancer	9.42e-08	3.63e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PIK3CB—breast cancer	9.2e-08	3.54e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PTGS2—breast cancer	9.11e-08	3.51e-06	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—AKT1—breast cancer	9.07e-08	3.49e-06	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—AKT1—breast cancer	8.99e-08	3.46e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CAV1—breast cancer	8.69e-08	3.35e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PTEN—breast cancer	8.51e-08	3.28e-06	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PIK3CA—breast cancer	7.95e-08	3.06e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PTEN—breast cancer	7.95e-08	3.06e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PIK3CG—breast cancer	7.92e-08	3.05e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PIK3CD—breast cancer	6.96e-08	2.68e-06	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PIK3CA—breast cancer	6.89e-08	2.65e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ALB—breast cancer	6.87e-08	2.65e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—NOS3—breast cancer	6.57e-08	2.53e-06	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—AKT1—breast cancer	6.5e-08	2.5e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PIK3CB—breast cancer	6.07e-08	2.34e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PTGS2—breast cancer	6.01e-08	2.31e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PIK3CA—breast cancer	6e-08	2.31e-06	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—AKT1—breast cancer	5.63e-08	2.17e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PIK3CA—breast cancer	5.61e-08	2.16e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PTEN—breast cancer	5.24e-08	2.02e-06	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—AKT1—breast cancer	4.9e-08	1.89e-06	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—AKT1—breast cancer	4.58e-08	1.76e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PIK3CA—breast cancer	3.7e-08	1.42e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—AKT1—breast cancer	3.02e-08	1.16e-06	CbGpPWpGaD
